跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
羅 力瑋
教授
醫學系內科學科
電子郵件
lwlo
vghtpe.gov
tw
網站
https://cv.nycu.edu.tw/?action=member&id=28
h-index
h10-index
h5-index
8965
引文
53
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
4080
引文
33
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
675
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2006
2024
每年研究成果
概覽
指紋
網路
研究成果
(397)
類似的個人檔案
(6)
指紋
查看啟用 Li-Wei Lo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Ablation
31%
Ablation Outcomes
8%
Ablation Therapy
6%
Arrhythmia
6%
Arrhythmogenic Right Ventricular Cardiomyopathy
8%
Arrhythmogenic Right Ventricular Dysplasia
7%
Atrial Arrhythmia
7%
Atrial Fibrillation
98%
Atrial Fibrillation Ablation
32%
Atrial Fibrillation Recurrence
16%
Atrial Substrate
20%
Atrial Tachycardia
7%
Atrium
6%
Catheter Ablation
69%
CHA2DS2-VASc Score
13%
Clinical Characteristics
6%
Clinical Outcomes
7%
Complex Fractionated Atrial Electrograms
6%
Confidence Interval
9%
Dominant Frequency
6%
Electrogram
10%
Electrophysiological Characteristics
12%
Endocardium
5%
Hazard Ratio
8%
Heart Failure
8%
Ischemic Stroke
6%
Left Atrial
13%
Left Atrial Diameter
5%
Left Atrium
14%
National Cohort Study
11%
New-onset Atrial Fibrillation
5%
Non-paroxysmal Atrial Fibrillation
9%
Oral Anticoagulants
6%
Paroxysmal Atrial Fibrillation
29%
Persistent Atrial Fibrillation
14%
Pulmonary Vein
13%
Pulmonary Vein Isolation
23%
Radiofrequency Catheter Ablation
7%
Renal Denervation
6%
Right Atrium
6%
Risk of Ischemic Stroke
6%
Sinus Rhythm
10%
Stroke Risk
6%
Structural Remodeling
6%
Substrate Properties
10%
Sudden Cardiac Death
6%
Superior Vena Cava
7%
Taiwan
7%
Ventricular Arrhythmia
27%
Ventricular Tachycardia
10%
Medicine and Dentistry
Ablation
76%
Ablation Therapy
8%
Antithrombotic
8%
Apoplexy
14%
Arrhythmogenic Right Ventricular Dysplasia
13%
Atrial Electrogram
6%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
10%
Atrial Flutter
9%
Atrium
5%
Brain Ischemia
7%
Cardiac Dysrhythmia
6%
Cardiovascular System
8%
CHA2DS2-VASc Score
10%
Cohort Analysis
9%
Congestive Heart Failure
9%
Electrocardiogram
7%
Electrography
15%
Endocardium
6%
Hazard Ratio
7%
Heart Ventricle Arrhythmia
18%
Left Atrium
13%
Myocardial Disease
8%
Paroxysmal Atrial Fibrillation
26%
Persistent Atrial Fibrillation
11%
Premature Ventricular Contraction
5%
Pulmonary Vein
18%
Pulmonary Vein Isolation
22%
Recurrent Disease
31%
Risk Stratification
5%
Sinus Rhythm
9%
Sudden Cardiac Death
6%
Superior Vena Cava
6%
Supraventricular Tachycardia
9%
Tachyarrhythmia
5%
Ventricular Outflow Tract
7%
Ventricular Tachycardia
20%
